|
Transplantation
Citations 111-120 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice
- Steven Bair, Emily Spaulding, Jaakko Parkkinen, Howard M. Shulman, Vladimir Lesnikov, Mary Beauchamp, François Canonne-Hergaux, Kris V. Kowdley, and H. Joachim Deeg
Blood 2009; 113: 1841-1844.
[Abstract]
[Full text]
[PDF]
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
- Robert R. Jenq, Christopher G. King, Christine Volk, David Suh, Odette M. Smith, Uttam K. Rao, Nury L. Yim, Amanda M. Holland, Sydney X. Lu, Johannes L. Zakrzewski, Gabrielle L. Goldberg, Adi Diab, Onder Alpdogan, Olaf Penack, Il-Kang Na, Lucy W. Kappel, Jedd D. Wolchok, Alan N. Houghton, Miguel-Angel Perales, and Marcel R. M. van den Brink
Blood 2009; 113: 1574-1580.
[Abstract]
[Full text]
[PDF]
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Linda Vrooman, Israel Lowy, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, James R. Mason, Edwin P. Alyea, Robert J. Soiffer, and Edward D. Ball
Blood 2009; 113: 1581-1588.
[Abstract]
[Full text]
[PDF]
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
- Michael J. Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis-Mortari, Bruce R. Blazar, and Jonathan S. Serody
Blood 2009; 113: 1365-1374.
[Abstract]
[Full text]
[PDF]
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison
- Jan J. Cornelissen, Bronno van der Holt, Gregor E. G. Verhoef, Mars B. van 't Veer, Marinus H. J. van Oers, Harry C. Schouten, Gert Ossenkoppele, Pieter Sonneveld, Johan Maertens, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Pierre W. Wijermans, Douwe H. Biesma, Shulamit Wittebol, Paul J. Voogt, Joke W. Baars, Pierre Zachée, Leo F. Verdonck, Bob Löwenberg, and Adriaan W. Dekker, on behalf of the Dutch-Belgian HOVON Cooperative Group
Blood 2009; 113: 1375-1382.
[Abstract]
[Full text]
[PDF]
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
- Emmanuel Gyan, Charles Foussard, Philippe Bertrand, Patrick Michenet, Steven Le Gouill, Christian Berthou, Hervé Maisonneuve, Vincent Delwail, Rémi Gressin, Philippe Quittet, Jean-Pierre Vilque, Bernard Desablens, Jérôme Jaubert, Jean-François Ramée, Nina Arakelyan, Antoine Thyss, Cécile Moluçon-Chabrot, Roselyne Delépine, Noël Milpied, Philippe Colombat, and Eric Deconinck, for the Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang (GOELAMS)
Blood 2009; 113: 995-1001.
[Abstract]
[Full text]
[PDF]
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
- Jakub Tolar, Akemi Ishida-Yamamoto, Megan Riddle, Ron T. McElmurry, Mark Osborn, Lily Xia, Troy Lund, Catherine Slattery, Jouni Uitto, Angela M. Christiano, John E. Wagner, and Bruce R. Blazar
Blood 2009; 113: 1167-1174.
[Abstract]
[Full text]
[PDF]
Solid cancers after allogeneic hematopoietic cell transplantation
- J. Douglas Rizzo, Rochelle E. Curtis, Gérard Socié, Kathleen A. Sobocinski, Ethel Gilbert, Ola Landgren, Lois B. Travis, William D. Travis, Mary E. D. Flowers, Debra L. Friedman, Mary M. Horowitz, John R. Wingard, and H. Joachim Deeg
Blood 2009; 113: 1175-1183.
[Abstract]
[Full text]
[PDF]
IL-17 contributes to CD4-mediated graft-versus-host disease
- Lucy W. Kappel, Gabrielle L. Goldberg, Christopher G. King, David Y. Suh, Odette M. Smith, Cassandra Ligh, Amanda M. Holland, Jeremy Grubin, Nicholas M. Mark, Chen Liu, Yoichiro Iwakura, Glenn Heller, and Marcel R. M. van den Brink
Blood 2009; 113: 945-952.
[Abstract]
[Full text]
[PDF]
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI
- Nainong Li, Ying Chen, Wei He, Tangsheng Yi, Dongchang Zhao, Chunyan Zhang, Chia-Lei Lin, Ivan Todorov, Fouad Kandeel, Stephen Forman, and Defu Zeng
Blood 2009; 113: 953-962.
[Abstract]
[Full text]
[PDF]
|
|
